Barbara Lipert

633 total citations
12 papers, 490 citations indexed

About

Barbara Lipert is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Barbara Lipert has authored 12 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Barbara Lipert's work include DNA Repair Mechanisms (3 papers), CAR-T cell therapy research (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Barbara Lipert is often cited by papers focused on DNA Repair Mechanisms (3 papers), CAR-T cell therapy research (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Barbara Lipert collaborates with scholars based in New Zealand, Poland and United States. Barbara Lipert's co-authors include Francis W. Hunter, Géraldine Gebhart, Martine Piccart, Christos Sotiriou, Françoise Rothé, Stephen M. F. Jamieson, Jolanta Jura, William R. Wilson, Michael P. Hay and Mateusz Wilamowski and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

Barbara Lipert

11 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Lipert New Zealand 9 229 194 125 84 72 12 490
Ann Tomanek‐Chalkley United States 12 125 0.5× 188 1.0× 31 0.2× 83 1.0× 56 0.8× 22 462
Michal Sobecki France 9 159 0.7× 221 1.1× 28 0.2× 215 2.6× 144 2.0× 12 654
Nikko Brix Germany 8 244 1.1× 155 0.8× 72 0.6× 132 1.6× 58 0.8× 13 503
Nancy Bogdan United States 8 133 0.6× 206 1.1× 132 1.1× 40 0.5× 59 0.8× 10 482
Maya Datt Joshi United States 9 179 0.8× 479 2.5× 116 0.9× 143 1.7× 113 1.6× 14 644
Meagan E. Anderson United States 8 89 0.4× 235 1.2× 127 1.0× 230 2.7× 38 0.5× 8 634
Joanna Stachura Poland 11 99 0.4× 155 0.8× 62 0.5× 55 0.7× 26 0.4× 21 417
Marcin Ziętek Poland 12 245 1.1× 200 1.0× 16 0.1× 137 1.6× 104 1.4× 57 487
Victor Yazbeck United States 12 165 0.7× 220 1.1× 19 0.2× 55 0.7× 43 0.6× 34 472
Marlene R.D. Quadros United States 7 189 0.8× 201 1.0× 64 0.5× 42 0.5× 60 0.8× 8 370

Countries citing papers authored by Barbara Lipert

Since Specialization
Citations

This map shows the geographic impact of Barbara Lipert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Lipert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Lipert more than expected).

Fields of papers citing papers by Barbara Lipert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Lipert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Lipert. The network helps show where Barbara Lipert may publish in the future.

Co-authorship network of co-authors of Barbara Lipert

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Lipert. A scholar is included among the top collaborators of Barbara Lipert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Lipert. Barbara Lipert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lipert, Barbara, Aziza Khan, Gitte Dam, et al.. (2025). CRISPR screens with trastuzumab emtansine in HER2-positive breast cancer cell lines reveal new insights into drug resistance. Breast Cancer Research. 27(1). 48–48. 2 indexed citations
2.
Cheng, Gary J., Jagdish K. Jaiswal, Barbara Lipert, et al.. (2024). Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers. Journal of Medicinal Chemistry. 67(14). 12366–12385.
3.
Lee, Tet Woo, et al.. (2019). Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia. International Journal of Radiation Biology. 95(12). 1597–1612. 37 indexed citations
4.
Lipert, Barbara, et al.. (2019). Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361. Biochemical Pharmacology. 169. 113641–113641. 23 indexed citations
5.
Hunter, Francis W., Barbara Lipert, Françoise Rothé, et al.. (2019). Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer. British Journal of Cancer. 122(5). 603–612. 213 indexed citations
6.
Lipert, Barbara, Aziza Khan, Peter Tsai, et al.. (2019). Functional CRISPR knockout screens for modifiers of sensitivity to trastuzumab emtansine. Annals of Oncology. 30. iii22–iii22. 1 indexed citations
7.
Lipert, Barbara, Katarzyna Miękus, Janusz Jaszczyński, et al.. (2017). MCPIP1 contributes to clear cell renal cell carcinomas development. Angiogenesis. 20(3). 325–340. 56 indexed citations
8.
Lipert, Barbara, Mateusz Wilamowski, Andrzej Górecki, & Jolanta Jura. (2017). MCPIP1, alias Regnase-1 binds and cleaves mRNA of C/EBPβ. PLoS ONE. 12(3). e0174381–e0174381. 21 indexed citations
9.
Ferrán, Marta, Barbara Lipert, Jolanta Jura, et al.. (2016). MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A. Journal of Investigative Dermatology. 136(8). 1599–1607. 36 indexed citations
10.
Lipert, Barbara, Dominika Berdecka, Sylwia Kędracka–Krok, et al.. (2015). Monocyte Chemoattractant Protein-Induced Protein 1 (MCPIP1) Enhances Angiogenic and Cardiomyogenic Potential of Murine Bone Marrow-Derived Mesenchymal Stem Cells. PLoS ONE. 10(7). e0133746–e0133746. 24 indexed citations
11.
Lipert, Barbara, Paulina Węgrzyn, Henrike Sell, et al.. (2014). Monocyte chemoattractant protein-induced protein 1 impairs adipogenesis in 3T3-L1 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(4). 780–788. 32 indexed citations
12.
Góralczyk, Anna, Łukasz Skalniak, Agnieszka Cierniak, et al.. (2012). Effect of silver nanoparticles on human primary keratinocytes. Biological Chemistry. 394(1). 113–123. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann Tomanek‐Chalkley Breakdown of academic impact, for papers by Michal Sobecki Breakdown of academic impact, for papers by Nikko Brix Breakdown of academic impact, for papers by Nancy Bogdan Breakdown of academic impact, for papers by Maya Datt Joshi Breakdown of academic impact, for papers by Meagan E. Anderson Breakdown of academic impact, for papers by Joanna Stachura Breakdown of academic impact, for papers by Marcin Ziętek Breakdown of academic impact, for papers by Victor Yazbeck Breakdown of academic impact, for papers by Marlene R.D. Quadros
Rankless by CCL
2026